PROPRIUS PHARMACEUTICALS
Proprius Pharmaceuticals is a San Diego-based drug developer focused on rheumatology and autoimmune diseases. The company offers two early clinical-stage therapeutic candidates comprising a product to treat pain and a product to treat rheumatoid arthritis. Proprius Pharmaceuticals was founded in 2005.
PROPRIUS PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.propriuspharma.com
Total Employee:
1+
Status:
Closed
Contact:
858-436-1816
Total Funding:
11 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Orca Pharmaceuticals
Orca Pharmaceuticals is a new biotechnology startup focusing on treating autoimmune diseases.
Founder
Investors List
Fog City Capital
Fog City Capital investment in Series A - Proprius Pharmaceuticals
Windamere Venture Partners
Windamere Venture Partners investment in Series A - Proprius Pharmaceuticals
Forward Ventures
Forward Ventures investment in Series A - Proprius Pharmaceuticals
CDIB BioScience Ventures
CDIB BioScience Ventures investment in Series A - Proprius Pharmaceuticals
Atlas Venture
Atlas Venture investment in Series A - Proprius Pharmaceuticals
Official Site Inspections
http://www.propriuspharma.com
Unable to get host informations!!!
More informations about "Proprius Pharmaceuticals"
Proprius Pharmaceuticals - Crunchbase Company …
Proprius Pharmaceuticals is a San Diego-based drug developer focused on rheumatology and autoimmune diseases. The company offers two early …See details»
Proprius Pharmaceuticals - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Proprius Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Proprius Pharmaceuticals Inc - Company Profile and News
Company profile page for Proprius Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Proprius Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Proprius Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 literature, Drug:PRO-515.See details»
Proprius Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 12264 El Camino Real Suite 300. San Diego, California, 92130, United States. 858-436-1816See details»
PROPRIUS PHARMACEUTICALS, INC. - NPI 1730357658 - Clinical …
Feb 13, 2008 NPI Profile for Proprius Pharmaceuticals, Inc. in 12264 El Camino Real Ste 350 San Diego, Ca 92130. Phone: (858) 436-1816 . Taxonomy 291U00000XSee details»
Proprius Pharmaceuticals - Ownership and Business Overview
Feb 25, 2008 Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008.The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which …See details»
Proprius Pharmaceuticals - CoBee Company Profile & Funding …
Proprius Pharmaceuticals is a San Diego-based drug developer focused on rheumatology and autoimmune diseases. The company offers two early clinical-stage therapeutic candidates …See details»
Proprius Pharmaceuticals Inc., Michael J. Walsh,
[email protected]: Phone: 1-858-436-1816: Website: www.propriuspharma.com Fax: 1-858-259-8941: Summary ; Executive Details ; Board Members ; Business Information The …See details»
Proprius Pharma - Founders and Board of Directors - Tracxn
Sep 28, 2024 Proprius Pharma founders & board of directors. Personalized medicine solutions in rheumatology and other autoimmune diseases. 2005 • San Diego (United States) • …See details»
Proprius Pharmaceuticals Secures Up To $17MM In Series A …
SAN DIEGO, Jan. 8 /PRNewswire/ -- Proprius Pharmaceuticals, Inc. today announced the completion of a Series A financing. The Series A round will provide Proprius with $11 million to …See details»
Proprius Pharmaceuticals, Inc. - SignalHire
Proprius Pharmaceuticals, Inc. is a biotechnology company based out of 12264El Camino Real, San Diego, California, United States.See details»
AlphaRx Inc.: Exhibit 99.1 - Prepared by TNT Filings Inc. - SEC.gov
Proprius is a privately-held and venture-backed organization, with financing provided by Fog City Fund, a life sciences fund established by St. Paul Venture Capital, and Windamere Venture …See details»
President & CEO - Proprius Pharmaceuticals, Inc. - LinkedIn
President & CEO at Proprius Pharmaceuticals, Inc. · Experience: Proprius Pharmaceuticals, Inc. · Location: San Diego · 1 connection on LinkedIn. View Michael Walsh’s profile on LinkedIn, a ...See details»
Proprius Pharmaceuticals Inc. Asset Profile | Preqin
Www.propriuspharma.com Company Stage Acquired Total Amount Raised Subscriber access only Time to go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on …See details»
Cypress Buying Proprius Pharma - PE Hub
Feb 26, 2008 Cypress Bioscience Inc. (Nasdaq: CYPB) has agreed to acquire Proprius Pharmaceuticals Inc., a San Diego-based drug developer focused on rheumatology and …See details»
Articles about Proprius Pharmaceuticals - BioSpace
Email: [email protected]. Show jobs for this employer 6 articles about Proprius Pharmaceuticals. Cypress Bioscience Inc. Closes Acquisition of Proprius Pharmaceuticals. …See details»
Proprius Pharmaceuticals - CB Insights
Explore {Proprius Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Cypress inks $75M deal to acquire Proprius | Fierce Biotech
Feb 25, 2008 Cypress Bioscience has inked a deal to buy Proprius Pharmaceuticals in a deal that starts out at $37.5 million up front and goes up to $75 million if its gamble on new …See details»
AlphaRx Inc. And Proprius Pharmaceuticals Announce License
Apr 11, 2006 AlphaRx Inc. And Proprius Pharmaceuticals Announce License Agreement For Indaflex(TM), A Phase II Topical NSAID For Osteoarthritis - read this article along with other …See details»